From: Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women
Age | Region* | Personal History of cancer | Family members/ type of cancer | Gene | Mutation | Protein change |
---|---|---|---|---|---|---|
60 | South | – | – | BRCA1 | c1140dupG | p.Lys381Glufs*3 |
45 | Central | Breast Ca | – | BRCA1 | c.1140dupG | p.Lys381Glufs*3 |
52 | Western | Breast Ca | Sister (breast) | BRCA1 | c.1140dupG | p.Lys381Glufs*3 |
52 | Central | – | – | BRCA1 | c.1140dupG | p.Lys381Glufs*3 |
48 | Western | – | – | BRCA1 | c.1140dupG | p.lys381Glufs*3 |
40 | Eastern | – | – | BRCA1 | c1140dupG | p.Lys381Glufs*3 |
45 | Central | – | Sister (breast/ovarian) Father (Lung) | BRCA1 | c.1140dupG | p.Lys381Glufs*3 |
43 | Central | Breast Ca | Mother and Sister (breast) | BRCA1 | c.1140dupG | p.Lys381Glufs*3 |
41 | Eastern | – | – | BRCA1 | c.1140dupG | p.Lys381Glufs*3 |
59 | Northern | – | – | BRCA1 | c.5530del | p.Leu1844Serfs*11 |
67 | Central | – | – | BRCA1 | c.5530del | p.Leu1844Sarfs*11 |
49 | Central | Breast Ca | – | BRCA1 | c.5530del | p.Leu1844Serfs*11 |
56 | Central | – | Sister (breast) | BRCA1 | c.5095C > T | p.Arg1699Trp |
69 | Southern | – | – | BRCA1 | c.2572C > T | p.Gln858* |
48 | Central | Pheochromocytoma, Breast Ca | Brother (colon Ca) | BRCA1 | c.2405_2406del | p.Val802Glufs*7 |
38 | Central | – | – | BRCA1 | c.2410_2413del | p.gln804Valfs*10 |
56 | Southern | – | Sister (breast) | BRCA1 | c.1426_1433del | p.His476* |
62 | Northern | – | – | BRCA1 | c.5074 + 2 T > T | |
50 | Northern | – | – | BRCA1 | c.5095C > T | p.Arg1699Trp |
53 | Central | – | Sister (breast/ovarian) Father (Colon) | BRCA1 | c.135-1del | |
43 | Central | – | – | BRCA1 | c.1016del | p.Lys339Argfs*2 |
56 | Central | – | – | BRCA1 | c.69del | p.Glu23Valfs*17 |
35 | Southern | – | – | BRCA1 | c.708_711dupTGAA | p.His228* |
50 | Northern | – | – | BRCA2 | c.7007G > A | p.Arg2336His |
41 | Central | – | – | BRCA2 | c.5762_5772del | p.Phe1921Serfs*3 |